{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:46:52Z","timestamp":1780789612643,"version":"3.54.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10787-024-01446-7","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T11:02:22Z","timestamp":1711018942000},"page":"1005-1015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-8941","authenticated-orcid":false,"given":"Bruno","family":"Bonaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"1446_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3917\/heg.123.0199","volume":"12","author":"S Artru-Voegel\u00e9","year":"2022","unstructured":"Artru-Voegel\u00e9 S, Sinniger V, Batandier C, Tropr\u00e8s I, Pellissier S, Bonaz B (2022) Contributions of hypnosis in Crohn\u2019s disease management: interests and preliminary results of HypnoCrohn study. Hegel 12:199\u2013212","journal-title":"Hegel"},{"key":"1446_CR2","doi-asserted-by":"crossref","unstructured":"Badran BW, Yu AB, Adair D, Mappin G, DeVries WH, Jenkins DD, George MS, Bikson M (2019) Laboratory administration of transcutaneous auricular vagus nerve stimulation (taVNS): technique, targeting, and considerations. J Vis Exp 14310.3791\/58984.","DOI":"10.3791\/58984"},{"issue":"9","key":"1446_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1365-2036.2011.04612.x","volume":"33","author":"S Ben-Horin","year":"2011","unstructured":"Ben-Horin S, Chowers Y (2011) Review article: loss of response to anti-TNF treatments in Crohn\u2019s disease. Aliment Pharmacol Ther 33(9):987\u2013995","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1446_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2468-1253(19)30324-3","volume":"5","author":"CJ Black","year":"2020","unstructured":"Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC (2020a) Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 5(2):117\u2013131","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"1446_CR5","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gutjnl-2020-321191","volume":"69","author":"CJ Black","year":"2020","unstructured":"Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC (2020b) Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 69(8):1441\u20131451","journal-title":"Gut"},{"issue":"10","key":"1446_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14456","volume":"34","author":"B Bonaz","year":"2022","unstructured":"Bonaz B (2022) Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction. Neurogastroenterol Motil 34(10):e14456","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"1446_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.gastro.2012.10.003","volume":"144","author":"BL Bonaz","year":"2013","unstructured":"Bonaz BL, Bernstein CN (2013) Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144(1):36\u201349","journal-title":"Gastroenterology"},{"issue":"3","key":"1446_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/nmo.12076","volume":"25","author":"B Bonaz","year":"2013","unstructured":"Bonaz B, Picq C, Sinniger V, Mayol JF, Claren\u00e7on D (2013) Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 25(3):208\u2013221","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"1446_CR9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/nmo.12792","volume":"28","author":"B Bonaz","year":"2016","unstructured":"Bonaz B, Sinniger V, Hoffmann D, Claren\u00e7on D, Mathieu N, Dantzer C, Vercueil L, Picq C, Trocm\u00e9 C, Faure P, Cracowski JL, Pellissier S (2016) Chronic vagus nerve stimulation in Crohn\u2019s disease: a 6-month follow-up pilot study. Neurogastroenterol Motil 28(6):948\u2013953","journal-title":"Neurogastroenterol Motil"},{"key":"1446_CR10","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fimmu.2017.01452","volume":"8","author":"B Bonaz","year":"2017","unstructured":"Bonaz B, Sinniger V, Pellissier S (2017) The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol 8:1452","journal-title":"Front Immunol"},{"key":"1446_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz B, Bazin T, Pellissier S (2018) The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front Neurosci 12:49","journal-title":"Front Neurosci"},{"key":"1446_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.650971","volume":"15","author":"B Bonaz","year":"2021","unstructured":"Bonaz B, Sinniger V, Pellissier S (2021a) Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases. Front Neurosci 15:650971","journal-title":"Front Neurosci"},{"issue":"1","key":"1446_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tins.2020.09.009","volume":"44","author":"B Bonaz","year":"2021","unstructured":"Bonaz B, Lane RD, Oshinsky ML, Kenny PJ, Sinha R, Mayer EA, Critchley HD (2021b) Diseases, Disorders, and Comorbidities of Interoception. Trends Neurosci 44(1):39\u201351","journal-title":"Trends Neurosci"},{"issue":"4","key":"1446_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/1745691613491271","volume":"8","author":"WR Boot","year":"2013","unstructured":"Boot WR, Simons DJ, Stothart C, Stutts C (2013) The Pervasive Problem With Placebos in Psychology: Why Active Control Groups Are Not Sufficient to Rule Out Placebo Effects. Perspect Psychol Sci 8(4):445\u2013454","journal-title":"Perspect Psychol Sci"},{"key":"1446_CR15","doi-asserted-by":"crossref","unstructured":"Brock C, Brock B, Aziz Q, M\u00f8ller HJ, Pfeiffer Jensen M, Drewes AM, Farmer AD (2017) Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and Tumor necrosis factor-alpha. Neurogastroenterol Motil 29(5).","DOI":"10.1111\/nmo.12999"},{"issue":"5","key":"1446_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.amepre.2009.06.021","volume":"37","author":"DW Brown","year":"2009","unstructured":"Brown DW, Anda RF, Tiemeier H, Felitti VJ, Edwards VJ, Croft JB, Giles WH (2009) Adverse childhood experiences and the risk of premature mortality. Am J Prev Med 37(5):389\u2013396","journal-title":"Am J Prev Med"},{"issue":"4","key":"1446_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5217\/ir.2017.15.4.434","volume":"15","author":"W Chan","year":"2017","unstructured":"Chan W, Chen A, Tiao D, Selinger C, Leong R (2017) Medication adherence in inflammatory bowel disease. Intest Res 15(4):434\u2013445","journal-title":"Intest Res"},{"issue":"9","key":"1446_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1365-2036.2012.05057.x","volume":"35","author":"M Chaparro","year":"2012","unstructured":"Chaparro M, Guerra I, Mu\u00f1oz-Linares P, Gisbert JP (2012) Systematic review: antibodies and anti-TNF-\u03b1 levels in inflammatory bowel disease. Aliment Pharmacol Ther 35(9):971\u2013986","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1446_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-019-0669-6","volume":"21","author":"B Click","year":"2019","unstructured":"Click B, Regueiro M (2019) Managing risks with biologics. Curr Gastroenterol Rep 21(2):1","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"1446_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/aphw.12323","volume":"14","author":"E Dent","year":"2022","unstructured":"Dent E, Davinson N, Wilkie S (2022) The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Appl Psychol Health Well Being 14(2):626\u2013644","journal-title":"Appl Psychol Health Well Being"},{"issue":"2","key":"1446_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/apt.17790","volume":"59","author":"J Devenney","year":"2024","unstructured":"Devenney J, Hasan SS, Morris J, Whorwell PJ, Vasant DH (2024) Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis. Aliment Pharmacol Ther 59(2):269\u2013277","journal-title":"Aliment Pharmacol Ther"},{"key":"1446_CR22","doi-asserted-by":"crossref","unstructured":"D'Haens G, Eberhardson M, Cabrijan Z, Danese S, van den Berg R, L\u00f6wenberg M, Fiorino G, Schuurman PR, Lind G, Almqvist P, Olofsson PS, Tracey KJ, Hanauer SB, Zitnik R, Chernoff D, Levine YA (2023) Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn's disease patients: a prospective open label study. J Crohns Colitis Sep 21:jjad151.","DOI":"10.1093\/ecco-jcc\/jjad151"},{"issue":"1","key":"1446_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/03009742.2020.1764617","volume":"50","author":"AM Drewes","year":"2021","unstructured":"Drewes AM, Brock C, Rasmussen SE, M\u00f8ller HJ, Brock B, Deleuran BW, Farmer AD, Pfeiffer-Jensen M (2021) Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study. Scand J Rheumatol 50(1):20\u201327","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"1446_CR24","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","volume":"154","author":"DA Drossman","year":"2018","unstructured":"Drossman DA, Tack J, Ford AC, Szigethy E, T\u00f6rnblom H, Van Oudenhove L (2018) Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report. Gastroenterology 154(4):1140\u20131171","journal-title":"Gastroenterology"},{"issue":"28","key":"1446_CR25","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.3748\/wjg.v23.i28.5127","volume":"23","author":"B Ducarouge","year":"2017","unstructured":"Ducarouge B, Pelissier-Rota M, Powell R, Buisson A, Bonaz B, Jacquier-Sarlin M (2017) Involvement of CRF2 signaling in enterocyte differentiation. World J Gastroenterol 23(28):5127\u20135145","journal-title":"World J Gastroenterol"},{"issue":"12","key":"1446_CR26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","volume":"5","author":"KM Fairbrass","year":"2020","unstructured":"Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC (2020) Prevalence of irritable bowel syndrome type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 5(12):1053\u20131062","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1446_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(18)30310-8","volume":"4","author":"CE Flik","year":"2019","unstructured":"Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, Whorwell PJ, de Wit NJ (2019) Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 4(1):20\u201331","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"1446_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2036.2010.04328.x","volume":"32","author":"AC Ford","year":"2010","unstructured":"Ford AC, Moayyedi P (2010) Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 32(2):144\u2013158","journal-title":"Aliment Pharmacol Ther"},{"issue":"10414","key":"1446_CR29","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","volume":"402","author":"AC Ford","year":"2023","unstructured":"Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA, ATLANTIS trialists, (2023) Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 402(10414):1773\u20131785","journal-title":"Lancet"},{"key":"1446_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fpsyt.2020.00229","volume":"11","author":"A Fournier","year":"2020","unstructured":"Fournier A, Mondillon L, Luminet O, Canini F, Mathieu N, Gauchez AS, Dantzer C, Bonaz B, Pellissier S (2020) Interoceptive abilities in inflammatory bowel diseases and irritable bowel syndrome. Front Psychiatry 11:229","journal-title":"Front Psychiatry"},{"key":"1446_CR31","doi-asserted-by":"crossref","unstructured":"Ghosh S, Sinha JK, Ghosh S, Sharma H, Bhaskar R, Narayanan KB (2023) A comprehensive review of emerging trends and innovative therapies in epilepsy management. Brain Sci Sep 13(9):1305.","DOI":"10.3390\/brainsci13091305"},{"issue":"2","key":"1446_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/biomedicines10020247","volume":"10","author":"YY Go","year":"2022","unstructured":"Go YY, Ju WM, Lee CM, Chae SW, Song JJ (2022) Different transcutaneous auricular vagus nerve stimulation parameters modulate the anti-inflammatory effects on lipopolysaccharide-induced acute inflammation in mice. Biomedicines 10(2):247","journal-title":"Biomedicines"},{"issue":"2","key":"1446_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jamacardio.2020.6050","volume":"6","author":"LC Godoy","year":"2021","unstructured":"Godoy LC, Frankfurter C, Cooper M, Lay C, Maunder R, Farkouh ME (2021) Association of adverse childhood experiences with cardiovascular disease later in life: a review. JAMA Cardiol 6(2):228\u2013235","journal-title":"JAMA Cardiol"},{"issue":"11","key":"1446_CR34","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/gut.52.11.1623","volume":"52","author":"WM Gonsalkorale","year":"2003","unstructured":"Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ (2003) Long-term benefits of hypnotherapy for irritable bowel syndrome. Gut 52(11):1623\u20131629","journal-title":"Gut"},{"issue":"1","key":"1446_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5056\/jnm.2010.16.1.30","volume":"16","author":"KA Gwee","year":"2010","unstructured":"Gwee KA (2010) Post-infectious irritable bowel syndrome, an inflammation-immunological model with relevance for other ibs and functional dyspepsia. J Neurogastroenterol Motil 16(1):30\u201334","journal-title":"J Neurogastroenterol Motil"},{"issue":"20","key":"1446_CR36","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.3748\/wjg.v29.i20.3185","volume":"29","author":"SI Halkj\u00e6r","year":"2023","unstructured":"Halkj\u00e6r SI, Lo B, Cold F, H\u00f8jer Christensen A, Holster S, K\u00f6nig J, Brummer RJ, Aroniadis OC, Lahtinen P, Holvoet T, Gluud LL, Petersen AM (2023) Fecal microbiota transplantation for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. World J Gastroenterol 29(20):3185\u20133202","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1446_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/00207144.2019.1553766","volume":"67","author":"SS Hasan","year":"2019","unstructured":"Hasan SS, Pearson JS, Morris J, Whorwell PJ (2019) Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face-to-face treatment. Int J Clin Exp Hypn 67(1):69\u201380","journal-title":"Int J Clin Exp Hypn"},{"issue":"7","key":"1446_CR38","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1053\/j.gastro.2021.02.058","volume":"160","author":"SS Hasan","year":"2021","unstructured":"Hasan SS, Whorwell PJ, Miller V, Morris J, Vasant DH (2021) Six vs 12 sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial. Gastroenterology 160(7):2605-2607.e3","journal-title":"Gastroenterology"},{"key":"1446_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0079-6123(08)62145-7","volume":"122","author":"W J\u00e4nig","year":"2000","unstructured":"J\u00e4nig W, Khasar SG, Levine JD, Miao FJ (2000) The role of vagal visceral afferents in the control of nociception. Prog Brain Res 122:273\u2013287","journal-title":"Prog Brain Res"},{"issue":"1","key":"1446_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cgh.2023.08.039","volume":"22","author":"DJ Katibian","year":"2024","unstructured":"Katibian DJ, Solitano V, Polk DB, Nguyen T, Ma C, Syal G, Kobayashi T, Hibi T, Buhl S, Ainsworth MA, Jairath V, Singh S (2024) Withdrawal of immunomodulators or TNF antagonists in patients with inflammatory bowel diseases in remission on combination therapy: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 22(1):22-33.e6","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"1446_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/apt.12449","volume":"38","author":"L Keefer","year":"2013","unstructured":"Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS (2013) Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther 38(7):761\u2013771","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1446_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11938-019-00221-w","volume":"17","author":"NC Knox","year":"2019","unstructured":"Knox NC, Forbes JD, Van Domselaar G, Bernstein CN (2019) The gut microbiome as a target for IBD treatment: are we there yet? Curr Treat Options Gastroenterol 17(1):115\u2013126","journal-title":"Curr Treat Options Gastroenterol"},{"key":"1446_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1572-0241.2000.01735.x","volume":"95","author":"NA Koloski","year":"2000","unstructured":"Koloski NA, Talley NJ, Boyce PM (2000) The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95:67\u201371","journal-title":"Am J Gastroenterol"},{"issue":"24","key":"1446_CR44","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1016\/j.cell.2021.10.013","volume":"184","author":"T Koren","year":"2021","unstructured":"Koren T, Yifa R, Amer M, Krot M, Boshnak N, Ben-Shaanan TL, Azulay-Debby H, Zalayat I, Avishai E, Hajjo H, Schiller M, Haykin H, Korin B, Farfara D, Hakim F, Kobiler O, Rosenblum K, Rolls A (2021) Insular cortex neurons encode and retrieve specific immune responses. Cell 184(24):5902-5915.e17","journal-title":"Cell"},{"issue":"7","key":"1446_CR45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1528-1157.1998.tb01155.x","volume":"39","author":"SE Krahl","year":"1998","unstructured":"Krahl SE, Clark KB, Smith DC, Browning RA (1998) Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39(7):709\u2013714","journal-title":"Epilepsia"},{"issue":"20","key":"1446_CR46","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1113\/JP281951","volume":"601","author":"SJ Leigh","year":"2023","unstructured":"Leigh SJ, Uhlig F, Wilmes L, Sanchez-Diaz P, Gheorghe CE, Goodson MS, Kelley-Loughnane N, Hyland NP, Cryan JF, Clarke G (2023) The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota-gut-brain axis perspective. J Physiol 601(20):4491\u20134538","journal-title":"J Physiol"},{"issue":"5","key":"1446_CR47","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","volume":"165","author":"JD Lewis","year":"2023","unstructured":"Lewis JD, Parlett LE, Jonsson Funk ML, Brensinger C, Pate V, Wu Q, Dawwas GK, Weiss A, Constant BD, McCauley M, Haynes K, Yang JY, Schaubel DE, Hurtado-Lorenzo A, Kappelman MD (2023) Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology 165(5):1197\u20131205","journal-title":"Gastroenterology"},{"issue":"2","key":"1446_CR48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ajg.2011.340","volume":"107","author":"P Lindfors","year":"2012","unstructured":"Lindfors P, Unge P, Arvidsson P, Nyhlin H, Bj\u00f6rnsson E, Abrahamsson H, Simr\u00e9n M (2012) Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol 107(2):276\u2013285","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1446_CR49","first-page":"82","volume":"77","author":"MA Mart\u00ednez-V\u00e1zquez","year":"2012","unstructured":"Mart\u00ednez-V\u00e1zquez MA, V\u00e1zquez-Elizondo G, Gonz\u00e1lez-Gonz\u00e1lez JA, Guti\u00e9rrez-Udave R, Maldonado-Garza HJ, Bosques-Padilla FJ (2012) Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: systematic review and meta-analysis. Rev Gastroenterol Mex 77(2):82\u201390","journal-title":"Rev Gastroenterol Mex"},{"issue":"6","key":"1446_CR50","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/j.1572-0241.2008.01845.x","volume":"103","author":"JE Mawdsley","year":"2008","unstructured":"Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS (2008) The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol 103(6):1460\u20131469","journal-title":"Am J Gastroenterol"},{"issue":"1\u20132","key":"1446_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.autneu.2010.10.007","volume":"160","author":"J Meregnani","year":"2011","unstructured":"Meregnani J, Claren\u00e7on D, Vivier M, Peinnequin A, Mouret C, Sinniger V, Picq C, Job A, Canini F, Jacquier-Sarlin M, Bonaz B (2011) Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 160(1\u20132):82\u201389","journal-title":"Auton Neurosci"},{"issue":"13","key":"1446_CR52","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1177\/13591053231173918","volume":"28","author":"S Minjoz","year":"2023","unstructured":"Minjoz S, Sinniger V, Hot P, Bonaz B, Pellissier S (2023) The burden of early life stress in chronic inflammatory bowel diseases. J Health Psychol 28(13):1204\u20131216","journal-title":"J Health Psychol"},{"key":"1446_CR53","doi-asserted-by":"crossref","unstructured":"Mion F, Pellissier S, Garros A, Damon H, Roman S & Bonaz B (2020) Transcutaneous auricular vagus nerve stimulation for the treatment of irritable bowel syndrome: a pilot, open-label study. Bioelectronics in Medicine 3 (1).","DOI":"10.2217\/bem-2020-0004"},{"key":"1446_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/bs.vh.2016.09.005","volume":"103","author":"S Pellissier","year":"2017","unstructured":"Pellissier S, Bonaz B (2017) The place of stress and emotions in the irritable bowel syndrome. Vitam Horm 103:327\u2013354","journal-title":"Vitam Horm"},{"issue":"11","key":"1446_CR55","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/apt.13202","volume":"41","author":"SL Peters","year":"2015","unstructured":"Peters SL, Muir JG, Gibson PR (2015) Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 41(11):1104\u20131115","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1446_CR56","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1053\/j.gastro.2019.10.036","volume":"158","author":"Rangan V, Ballou S, Shin A, Camilleri M; Beth Israel Deaconess Medical Center GI Motility Working Group; Lembo A","year":"2020","unstructured":"Rangan V, Ballou S, Shin A, Camilleri M; Beth Israel Deaconess Medical Center GI Motility Working Group; Lembo A (2020) Use of treatments for irritable bowel syndrome and patient satisfaction based on the IBS in america survey. Gastroenterology 158(3):786-788.e1","journal-title":"Gastroenterology"},{"issue":"6","key":"1446_CR57","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.brs.2018.08.010","volume":"11","author":"J Redgrave","year":"2018","unstructured":"Redgrave J, Day D, Leung H, Laud PJ, Ali A, Lindert R, Majid A (2018) Safety and tolerability of transcutaneous vagus nerve stimulation in humans; a systematic review. Brain Stimul 11(6):1225\u20131238","journal-title":"Brain Stimul"},{"issue":"1","key":"1446_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s42234-023-00124-3","volume":"9","author":"B Sahn","year":"2023","unstructured":"Sahn B, Pascuma K, Kohn N, Tracey KJ, Markowitz JF (2023) Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial. Bioelectronic Medicine 9(1):23","journal-title":"Bioelectronic Medicine"},{"key":"1446_CR59","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/138032a0","volume":"138","author":"H Selye","year":"1936","unstructured":"Selye H (1936) A syndrome produced by diverse nocuous agents. Nature 138:132","journal-title":"Nature"},{"issue":"14","key":"1446_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150052","volume":"6","author":"X Shi","year":"2021","unstructured":"Shi X, Hu Y, Zhang B, Li W, Chen JD, Liu F (2021) Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight 6(14):e150052","journal-title":"JCI Insight"},{"issue":"10","key":"1446_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13911","volume":"32","author":"V Sinniger","year":"2020","unstructured":"Sinniger V, Pellissier S, Fauvelle F, Trocm\u00e9 C, Hoffmann D, Vercueil L, Cracowski JL, David O, Bonaz B (2020) A 12-month pilot study outcomes of vagus nerve stimulation in Crohn\u2019s disease. Neurogastroenterol Motil 32(10):e13911","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"1446_CR62","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1365-2702.2006.01356.x","volume":"15","author":"GD Smith","year":"2006","unstructured":"Smith GD (2006) Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome. J Clin Nurs 15(6):678\u2013684","journal-title":"J Clin Nurs"},{"issue":"1","key":"1446_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1172\/JCI30085","volume":"117","author":"Stanculete MF, Dumitrascu DL, Drossman D (2021) Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome J Gastrointestin Liver Dis 30(4), 517\u2013525. Tach\u00e9 Y, Bonaz B","year":"2007","unstructured":"Stanculete MF, Dumitrascu DL, Drossman D (2021) Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome J Gastrointestin Liver Dis 30(4), 517\u2013525. Tach\u00e9 Y, Bonaz B (2007) Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 117(1):33\u201340","journal-title":"J Clin Invest"},{"issue":"10","key":"1446_CR64","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/ibd\/izz063","volume":"25","author":"LE Targownik","year":"2019","unstructured":"Targownik LE, Benchimol EI, Witt J, Bernstein CN, Singh H, Lix L, Tennakoon A, Zubieta AA, Coward S, Jones J, Kuenzig E, Murthy SK, Nguyen GC, Pe\u00f1a-S\u00e1nchez JN, Kaplan G (2019) The effect of initiation of anti-TNF therapy on the subsequent direct health care costs of inflammatory Bowel disease. Inflamm Bowel Dis 25(10):1718\u20131728","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"1446_CR65","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn.2016.111","volume":"17","author":"MH Teicher","year":"2016","unstructured":"Teicher MH, Samson JA, Anderson CM, Ohashi K (2016) The effects of childhood maltreatment on brain structure, function and connectivity. Nat Rev Neurosci 17(10):652\u2013666","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"1446_CR66","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ecco-jcc\/jjz051","volume":"13","author":"J Torres","year":"2019","unstructured":"Torres J, Ellul P, Langhorst J, Mikocka-Walus A, Barreiro-de Acosta M, Basnayake C, Ding NJS, Gilardi D, Katsanos K, Moser G, Opheim R, Palmela C, Pellino G, Van der Marel S, Vavricka SR (2019) European Crohn\u2019s and colitis organisation topical review on complementary medicine and psychotherapy in inflammatory Bowel disease. J Crohns Colitis 13(6):673\u2013685e","journal-title":"J Crohns Colitis"},{"issue":"5","key":"1446_CR67","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Sch\u00f6lmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, D\u2019Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Sch\u00f6lmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD (2021) STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160(5):1570\u20131583","journal-title":"Gastroenterology"},{"key":"1446_CR68","first-page":"1","volume":"9","author":"P Wetwittayakhlang","year":"2024","unstructured":"Wetwittayakhlang P, Bessissow T, Lakatos PL (2024) Novel and emerging drugs for the treatment of Crohn\u2019s disease: a review of phase II and III trials. Expert Opin Emerg Drugs 9:1\u201316","journal-title":"Expert Opin Emerg Drugs"},{"issue":"8414","key":"1446_CR69","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/S0140-6736(84)92793-4","volume":"2","author":"PJ Whorwell","year":"1984","unstructured":"Whorwell PJ, Prior A, Faragher EB (1984) Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 2(8414):1232\u20131234","journal-title":"Lancet"},{"issue":"36","key":"1446_CR70","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1523\/JNEUROSCI.0452-23.2023","volume":"43","author":"C Wienke","year":"2023","unstructured":"Wienke C, Grueschow M, Haghikia A, Zaehle T (2023) Phasic, event-related transcutaneous auricular vagus nerve stimulation modifies behavioral, pupillary, and low-frequency oscillatory power responses. J Neurosci 43(36):6306\u20136319","journal-title":"J Neurosci"},{"issue":"9","key":"1446_CR71","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/ecco-jcc\/jjab029","volume":"15","author":"M Zhao","year":"2021","unstructured":"Zhao M, G\u00f6nczi L, Lakatos PL, Burisch J (2021) The Burden of inflammatory bowel disease in Europe in 2020. J Crohns Colitis 15(9):1573\u20131587","journal-title":"J Crohns Colitis"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01446-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01446-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01446-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T14:16:31Z","timestamp":1712758591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01446-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01446-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has not disclosed any competing interests for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}